ATTO Conversion Disclosure
Deep Track Biotechnology Master Fund, Ltd. · SEC Form 4 · Filed Aug 10, 2026
Conversion
Calculated transaction value
$0
Deep Track Biotechnology Master Fund, Ltd. 10% owner
ATTO
Transaction date
Aug 6, 2026
Public filing date
Aug 10, 2026
Filing lag
Filed 4 days later
ATTO daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series C Redeemable Convertible Preferred Stock on Common Stock
- Quantity / price
- 18,181,818 shares @ $0
- SEC ownership
- Direct
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0001193125-26-342487
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Attovia Therapeutics, Inc. ATTO | Conversion | Aug 6, 2026 | Not reported |
| Attovia Therapeutics, Inc. ATTO Current | Conversion | Aug 6, 2026 | $0 |